We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$4.18B
AUM Growth
+$127M
Cap. Flow
-$138M
Cap. Flow %
-3.31%
Top 10 Hldgs %
18.27%
Holding
674
New
213
Increased
109
Reduced
103
Closed
236

Top Buys

Rank Stock Value
1
EA icon
Electronic Arts
EA
+$117M
2
BRBR icon
BellRing Brands
BRBR
+$64.8M
3
OMC icon
Omnicom Group
OMC
+$43.4M
4
GMED icon
Globus Medical
GMED
+$40.8M
5
CSX icon
CSX Corp
CSX
+$35.2M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$96M
2
SMG icon
ScottsMiracle-Gro
SMG
+$44.3M
3
SHOP icon
Shopify
SHOP
+$41.9M
4
CNK icon
Cinemark Holdings
CNK
+$41M
5
CARR icon
Carrier Global
CARR
+$36.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.13%
2 Industrials 13.12%
3 Healthcare 9.89%
4 Communication Services 9.48%
5 Technology 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNY icon
451
CALL
Alnylam Pharmaceuticals
ALNY
$27.5B
-36,000
Closed -$9.72M
ALNY icon
452
Alnylam Pharmaceuticals
ALNY
$27.5B
-74,185
Closed -$20M
ALNY icon
453
PUT
Alnylam Pharmaceuticals
ALNY
$27.5B
-21,000
Closed -$5.67M
AMAT icon
454
Applied Materials
AMAT
$403B
-21,002
Closed -$3.05M
AMC icon
455
AMC Entertainment Holdings
AMC
$2.52B
-27,475
Closed -$78.9K
ANGI icon
456
PUT
Angi Inc
ANGI
$229M
-263,100
Closed -$4.05M
ARCT icon
457
Arcturus Therapeutics
ARCT
$164M
-135,427
Closed -$1.43M
ARGX icon
458
argenx
ARGX
$53.4B
-2,000
Closed -$1.18M
ARKK icon
459
ARK Innovation ETF
ARKK
$5.64B
-240,000
Closed -$11.4M
ARQT icon
460
CALL
Arcutis Biotherapeutics
ARQT
$3.36B
-59,700
Closed -$934K
ASTL icon
461
CALL
Algoma Steel
ASTL
$406M
-175,100
Closed -$949K
AXP icon
462
PUT
American Express
AXP
$227B
-2,500
Closed -$673K
AXSM icon
463
CALL
Axsome Therapeutics
AXSM
$11.2B
-34,000
Closed -$3.97M
AZUL
464
PUT
DELISTED
Azul
AZUL
-1,014,800
Closed -$1.66M
BA icon
465
Boeing
BA
$171B
-129,927
Closed -$22.2M
BBIO icon
466
CALL
BridgeBio Pharma
BBIO
$15.7B
-30,000
Closed -$1.04M
BBIO icon
467
BridgeBio Pharma
BBIO
$15.7B
-6,750
Closed -$233K
BBWI icon
468
PUT
Bath & Body Works
BBWI
$4.06B
-200,000
Closed -$6.06M
BIDU icon
469
Baidu
BIDU
$37.7B
-84,200
Closed -$7.75M
BLD
470
DELISTED
TopBuild
BLD
-60,711
Closed -$18.5M
BMY icon
471
PUT
Bristol-Myers Squibb
BMY
$133B
-100,000
Closed -$6.1M
BOOT icon
472
CALL
Boot Barn
BOOT
$4.51B
-70,000
Closed -$7.52M
BOOT icon
473
Boot Barn
BOOT
$4.51B
-81,777
Closed -$8.79M
BTU icon
474
CALL
Peabody Energy
BTU
$2.6B
-100,000
Closed -$1.35M
CAR icon
475
CALL
Avis
CAR
$4.86B
-393,900
Closed -$29.9M

Similar funds

J. Goldman & Co's Q2 2025 Portfolio in Review

As of Q2 2025, J. Goldman & Co held 674 positions worth $4.18B, up 3.1% from $4.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

J. Goldman & Co withdrew a net $138M in Q2 2025, closing 236 positions and reducing 103 holdings. Its most notable exit was ScottsMiracle-Gro, an estimated $44.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, J. Goldman & Co opened a new position in BellRing Brands worth $56.2M.

  • J. Goldman & Co's largest Q2 2025 buy was BellRing Brands: 970,558 shares worth $56.2M.
  • J. Goldman & Co added most to Electronic Arts in Q2 2025, an estimated $117M increase.
  • J. Goldman & Co's biggest Q2 2025 reduction was Mastercard, cutting an estimated $96M.
  • J. Goldman & Co fully exited ScottsMiracle-Gro in Q2 2025, selling an estimated $44.3M.
  • J. Goldman & Co's ten largest holdings make up 18% of its $4.18B portfolio in Q2 2025.
  • J. Goldman & Co opened 213 new positions and closed 236 in Q2 2025.
  • J. Goldman & Co's portfolio value rose 3.1% quarter-over-quarter to $4.18B.

Based on J. Goldman & Co's 13F filing for Q2 2025, filed 14 Aug 2025.